Page last updated: 2024-08-24

mevastatin and Stroke

mevastatin has been researched along with Stroke in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amin-Hanjani, S; Huang, PL; Liao, JK; Moskowitz, MA; Stagliano, NE; Yamada, M	1

Other Studies

1 other study(ies) available for mevastatin and Stroke

Article	Year
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke, 2001, Volume: 32, Issue:4 Topics: Animals; Aorta; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Cerebrovascular Circulation; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; RNA, Messenger; Stroke; Treatment Outcome; Up-Regulation	2001

Article

Year

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice.

Stroke, 2001, Volume: 32, Issue:4

Topics: Animals; Aorta; Blood Flow Velocity; Blood Gas Analysis; Blood Pressure; Cerebrovascular Circulation; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoblotting; Lovastatin; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; RNA, Messenger; Stroke; Treatment Outcome; Up-Regulation

2001